Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related to Alzheimer's disease in individuals with mild cognitive impairment ...

April 22 (Reuters) - Laboratory operator Quest Diagnostics (DGX.N), opens new tab beat Wall Street estimates for first-quarter profit on Tuesday, helped by robust demand for its diagnostic tests.